194 related articles for article (PubMed ID: 26945752)
1. Comparison between MDCK and MDCK-SIAT1 cell lines as preferred host for cell culture-based influenza vaccine production.
Abdoli A; Soleimanjahi H; Jamali A; Mehrbod P; Gholami S; Kianmehr Z; Feizi N; Saleh M; Bahrami F; Mokhtari-Azad T; Abdoli M; Kheiri MT
Biotechnol Lett; 2016 Jun; 38(6):941-8. PubMed ID: 26945752
[TBL] [Abstract][Full Text] [Related]
2. Distinct susceptibility and applicability of MDCK derivatives for influenza virus research.
Lin SC; Kappes MA; Chen MC; Lin CC; Wang TT
PLoS One; 2017; 12(2):e0172299. PubMed ID: 28207898
[TBL] [Abstract][Full Text] [Related]
3. Generation of a High-Growth Influenza Vaccine Strain in MDCK Cells for Vaccine Preparedness.
Kim EH; Kwon HI; Park SJ; Kim YI; Si YJ; Lee IW; Kim SM; Kim SI; Ahn DH; Choi YK
J Microbiol Biotechnol; 2018 Jun; 28(6):997-1006. PubMed ID: 29642288
[TBL] [Abstract][Full Text] [Related]
4. Comparison of influenza virus yields and apoptosis-induction in an adherent and a suspension MDCK cell line.
Peschel B; Frentzel S; Laske T; Genzel Y; Reichl U
Vaccine; 2013 Nov; 31(48):5693-9. PubMed ID: 24113260
[TBL] [Abstract][Full Text] [Related]
5. Production of cell culture (MDCK) derived live attenuated influenza vaccine (LAIV) in a fully disposable platform process.
George M; Farooq M; Dang T; Cortes B; Liu J; Maranga L
Biotechnol Bioeng; 2010 Aug; 106(6):906-17. PubMed ID: 20589670
[TBL] [Abstract][Full Text] [Related]
6. MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells.
Oh DY; Barr IG; Mosse JA; Laurie KL
J Clin Microbiol; 2008 Jul; 46(7):2189-94. PubMed ID: 18480230
[TBL] [Abstract][Full Text] [Related]
7. Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturing.
Donis RO; ; Davis CT; Foust A; Hossain MJ; Johnson A; Klimov A; Loughlin R; Xu X; Tsai T; Blayer S; Trusheim H; Colegate T; Fox J; Taylor B; Hussain A; Barr I; Baas C; Louwerens J; Geuns E; Lee MS; Venhuizen O; Neumeier E; Ziegler T
Vaccine; 2014 Nov; 32(48):6583-90. PubMed ID: 24975811
[TBL] [Abstract][Full Text] [Related]
8. Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: in vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells.
Hussain AI; Cordeiro M; Sevilla E; Liu J
Vaccine; 2010 May; 28(22):3848-55. PubMed ID: 20307595
[TBL] [Abstract][Full Text] [Related]
9. The characteristics and antigenic properties of recently emerged subclade 3C.3a and 3C.2a human influenza A(H3N2) viruses passaged in MDCK cells.
Lin Y; Wharton SA; Whittaker L; Dai M; Ermetal B; Lo J; Pontoriero A; Baumeister E; Daniels RS; McCauley JW
Influenza Other Respir Viruses; 2017 May; 11(3):263-274. PubMed ID: 28164446
[TBL] [Abstract][Full Text] [Related]
10. High genetic stability in MDCK-SIAT1 passaged human influenza viruses.
Matsumoto S; Chong Y; Kang D; Ikematsu H
J Infect Chemother; 2019 Mar; 25(3):222-224. PubMed ID: 30241880
[TBL] [Abstract][Full Text] [Related]
11. Production and antigenic properties of influenza virus from suspension MDCK-siat7e cells in a bench-scale bioreactor.
Chu C; Lugovtsev V; Lewis A; Betenbaugh M; Shiloach J
Vaccine; 2010 Oct; 28(44):7193-201. PubMed ID: 20800699
[TBL] [Abstract][Full Text] [Related]
12. Comparison of N-linked glycosylation on hemagglutinins derived from chicken embryos and MDCK cells: a case of the production of a trivalent seasonal influenza vaccine.
Li J; Liu S; Gao Y; Tian S; Yang Y; Ma N
Appl Microbiol Biotechnol; 2021 May; 105(9):3559-3572. PubMed ID: 33937925
[TBL] [Abstract][Full Text] [Related]
13. [Optimization of culture condition for cultivation of influenza virus A on MDCK cell].
Zhao X; Zhou D
Wei Sheng Yan Jiu; 2014 Mar; 43(2):210-2, 218. PubMed ID: 24868970
[TBL] [Abstract][Full Text] [Related]
14. Higher titers of some H5N1 and recent human H1N1 and H3N2 influenza viruses in Mv1 Lu vs. MDCK cells.
Hamilton SB; Wyatt DE; Wahlgren BT; O'Dowd MK; Morrissey JM; Daniels DE; Lednicky JA
Virol J; 2011 Feb; 8():66. PubMed ID: 21314955
[TBL] [Abstract][Full Text] [Related]
15. Influenza viruses production: Evaluation of a novel avian cell line DuckCelt®-T17.
Petiot E; Proust A; Traversier A; Durous L; Dappozze F; Gras M; Guillard C; Balloul JM; Rosa-Calatrava M
Vaccine; 2018 May; 36(22):3101-3111. PubMed ID: 28571695
[TBL] [Abstract][Full Text] [Related]
16. Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines.
Shin D; Park KJ; Lee H; Cho EY; Kim MS; Hwang MH; Kim SI; Ahn DH
Virus Res; 2015 Jun; 204():40-6. PubMed ID: 25892718
[TBL] [Abstract][Full Text] [Related]
17. Measuring Influenza Neutralizing Antibody Responses to A(H3N2) Viruses in Human Sera by Microneutralization Assays Using MDCK-SIAT1 Cells.
Gross FL; Bai Y; Jefferson S; Holiday C; Levine MZ
J Vis Exp; 2017 Nov; (129):. PubMed ID: 29286446
[TBL] [Abstract][Full Text] [Related]
18. Rapid production of a H₉ N₂ influenza vaccine from MDCK cells for protecting chicken against influenza virus infection.
Ren Z; Lu Z; Wang L; Huo Z; Cui J; Zheng T; Dai Q; Chen C; Qin M; Chen M; Yang R
Appl Microbiol Biotechnol; 2015 Apr; 99(7):2999-3013. PubMed ID: 25646963
[TBL] [Abstract][Full Text] [Related]
19. [Generation of cell culture high-yield recombinant H3N2 subtype swine influenza vaccine candidate by reverse genetics].
Yang T; Liu M; Liu CG; Zhang Y; Liu DF; Chen H; Tong GZ
Bing Du Xue Bao; 2007 Nov; 23(6):471-6. PubMed ID: 18092685
[TBL] [Abstract][Full Text] [Related]
20. [Antiviral effect of «Kagocel» substance in vitro on influenza viruses H1N1, H1N1pdm09 and H3N2.].
Fediakina IT; Konopleva MV; Proshina ES; Linnik EV; Nikitina NI
Vopr Virusol; 2019; 64(3):125-131. PubMed ID: 31622059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
